$ZYME
Zymeworks Inc.
XNAS
Why is ZYME down today? It is at $26.24 (-8.79%), and our scanner flagged it 55 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ZYME spikes, and full due diligence on ZYME — key stats, earnings, dilution and insider activity. Free.
Get free $ZYME alerts the moment volume spikes
Our scanner flagged $ZYME 55 times in the last 30 days. Create a free account to track $ZYME, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $26.24
- Change today
- -8.79%
- Previous close
- $28.77
- 52-week range
- $13.60 – $29.75
- Market cap
- $2.04B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Avg daily volume
- 775K
- Exchange
- XNAS
- 5m
- 1.7x
- 15m
- 4.4x
- 1h
- 2.6x
- 1D
- 0.8x
Get free ZYME + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ZYME down today?
ZYME is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on ZYME today, peaking at 47.1x its normal volume. Fresh from the SEC: Zymeworks Inc.: U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying1 buys, 0 sells last 3 months (2/8 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hollywood Mark Officer | Acquired (grant/award) | +939 | added 0.7% | 134K | $21K at $22.22 | Jul 6, 26 |
Galbraith Kenneth Officer | Sold (automatic/other) | -30K 0.04% of company | sold 12% | 227K | $690K at $22.67 | Jan 12, 26 |
Galbraith Kenneth Officer | Other | 64K 0.09% of company | added 33% | 257K | n/a | Jan 12, 26 |
Moore Paul Andrew Officer | Sold (automatic/other) | -10K 0.01% of company | sold 16% | 48K | $217K at $22.67 | Jan 12, 26 |
Moore Paul Andrew Officer | Other | 18K 0.02% of company | added 44% | 58K | n/a | Jan 12, 26 |
Smith Jeffrey T L Officer | Sold (automatic/other) | -9K 0.01% of company | sold 26% | 27K | $211K at $22.67 | Jan 12, 26 |
Smith Jeffrey T L Officer | Other | 18K 0.02% of company | added 96% | 36K | n/a | Jan 12, 26 |
Hollywood Mark Officer | Sold (automatic/other) | -6K | sold 4.4% | 133K | $139K at $22.67 | Jan 12, 26 |
Hollywood Mark Officer | Other | 18K 0.02% of company | added 15% | 139K | n/a | Jan 12, 26 |
Patterson Leone D Officer | Acquired (grant/award) | +459 | n/a | 459 | $5K at $10.55 | Jan 6, 26 |
Moore Paul Andrew Officer | Sold (automatic/other) | -20K 0.03% of company | sold 39% | 31K | $505K at $25.10 | Jan 5, 26 |
Moore Paul Andrew Officer | Other | 37K 0.05% of company | added 100% | 51K | n/a | Jan 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
$ZYME Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ZYME Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
ZYME stock FAQ
Why is $ZYME down today?
ZYME is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on ZYME today, peaking at 47.1x its normal volume. Fresh from the SEC: Zymeworks Inc.: U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma. A material company disclosure like this is often the real catalyst behind a move of this size.
What is the ZYME stock price today?
ZYME last traded at $26.24, down 8.79% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live ZYME alerts?
The ZYME Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ZYME 55 times in the last 30 days.
What exchange is ZYME on?
ZYME (Zymeworks Inc.) trades on XNAS, with a market cap of about $2.04B.
Is ZYME good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ZYME for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.